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The generation of human IPSC line i10984 was carried out using E8
based media and feeder-free conditions. EBV-transformed B-lympho-
cyte cells from an 83-year old Alzheimer's Disease (AD) patient, gener-
ated by Coriell Institute For Medical Research, were employed. The
patient had a 15 year-history of progressive presenile dementia with aeg).
. This is an open access article underparent and three siblings of the patient also being affected (iPSC line
i11001). The patient was homozygous for the APOE4 allele. This was
conﬁrmed by a PCR-RFLP assay (Hixson and Vernier, 1990) carried out
with the lymphoblastoid cell line. (Fig. 1A).
The lymphoblastoid cells (LCs) were electroporated with OriP/
EBNA-1 based episomal plasmids expressing reprogramming factors
OCT4, SOX2, KLF-4, L-MYC, LIN28 and a p53 shRNA (Okita et al.,
2011). The APOE4/4 genotype of the generated iPS line was conﬁrmed
by sequencing (Fig. 1A). After several passages, a PCR for episomal vec-
tor backbone conﬁrmed that exogenous episomal factors were not
being expressed anymore (Fig. 1A).
i10984 iPSC colonies displayed a typical ES-like colony morphology
(Fig. 1B). Immunocyto-chemical analysis revealed expression of tran-
scription factors OCT4 and SOX2, and surface markers SSEA4 and TRA-
1–81, characteristic of pluripotent stem cells (Fig. 1B). The iPS cells ex-
hibited a normal karyotype (46, XX) by G-Banding analysis (Fig. 1B).
The cells also demonstrated differentiation capacity to three germ layers
using an embryoid body-based directed differentiation protocol, follow-
ed by immunostaining with markers corresponding to the three germ
layers i.e. ectoderm (PAX6), mesoderm (FOXC1) and endoderm
(GATA4) (Fig. 1C).Materials and methods
Cell culture
The LC line was cultured in RPMI-1640 Medium (Gibco™)
supplementedwith 15% FBS (MP Biomedicals), 1% penicillin/strepto-
mycin (Invitrogen™) and 1% GlutaMAX (Invitrogen™) at 37 °C and
5% CO2.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Generation and characterization of i10984 line. (A) Conﬁrmation of APOE4/4 status
of lymphoblastoid (source) line and i10984 iPS line by PCR-RFLP assay and Sanger
sequencing, respectively. (Sequencing trace is reverse complement of sense strand).
Product of OriP and EBNA PCR run with a positive control, shows episomal plasmids
have been lost by the iPSCs. (B) i10984 cellular morphology resembles ES-like
cell morphology. Immunoﬂuorescence staining for pluripotency markers OCT4,
SOX2, SSEA4, TRA-1–81 is positive. Karyotype is normal (46, XX). Scale bar: 100 μm.
(C) EB formation was induced, followed by directed differentiation to, and
immunoﬂuorescence staining for markers of the three germ layers: ectoderm: PAX6,
mesoderm: FOXC1, endoderm: GATA4. Scale bar: 100 μm.
Table 1
Antibodies used for immunocytochemistry.
Antibody Dilution Company (Cat #)
Pluripotency
markers
Rabbit anti-OCT4, 1:300 Cell Signalling
Technology #9656Rabbit anti-SOX2, 1:300
Mouse anti-SSEA4, 1:300
Mouse anti-TRA-1-81 1:300
Differentiation
markers
Rabbit anti-FOXC1 1:100 Bethyl Laboratories Inc.
#A303-520A
Rabbit anti-GATA4 1:200 Bethyl Laboratories Inc.
#A303-503A
Mouse anti-PAX6 1:100 Developmental Studies
Hybridoma Bank #AB
528427
Secondary
antibodies
CF488A goat
anti-mouse IgG (H + L)
1:1000 Biotium Inc. #20010
CF488A goat
anti-rabbit IgG (H + L)
1:1000 Biotium Inc. #20019
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LCs were reprogrammed by electroporating 200,000 cells with OriP/
EBNA-1-based episomal plasmids (the plasmids were a gift from Shinya
Yamanaka) encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, and shRNA of
p53 (Okita et al., 2011) using aNeon transfection system (Invitrogen™).
1 μg of each plasmid and 10 μl tip of the Neon microporator kit were
used for 2 pulses of 30 ms each at 1100 V. The cells were plated on
Matrigel (Corning®) coated plates, in E8 medium without TGF-β,
supplemented with 100 μM sodium butyrate. After 15–17 days,
colonies started to appear and when they reached a sufﬁcient size,were manually picked and plated onto Matrigel (Corning®) coated
plates, in complete E8 medium. Cells were passaged by exposing to
DPBS (without Ca++ & Mg++) for a few minutes, then scraping the
cell aggregates with a scraper, followed by mechanical trituration and
subculturing. Cells were frozen using CryoStor® (Sigma-Aldrich).
Polymerase chain reaction
PCR for OriP and EBNA-1 was carried out using primers as described
in Cai et al. (2015). PCR reaction was performed using Kapa HiFi Poly-
merase (Kapa Biosystems) with cycling conditions: 94 °C for 30 s,
55 °C for 30 s, 72 °C for 1 min for 35 cycles. Episomal vector pCXLE-
hUL was used as a positive control. The products were run on a 2% aga-
rose gel.
Genotyping of APOE sequence
PCR of APOE exon 4 was carried out using the primers:
Forward:5′CAGTCTCTCACACTCGTCCTGGC3′;Reverse: 5′CTGCTCC
TTCACCTCGTCCA3′.
PCR reaction was performed using Kapa HiFi Polymerase (Kapa
Biosystems) with cycling conditions: 94 °C for 30 s, 61 °C for 30 s,
72 °C for 1 min for 30 cycles.
Sanger sequencing was then performed on the PCR product using
the reverse primer by Euroﬁns Genomics.
APOE genotyping by RFLP assay
Genotyping for APOE status of the LCs was carried out by PCR ampli-
ﬁcation followed by HhaI digestion as described in (Hixson et al., 1990).
An APOE3/4 line DNA was run as a reference.
Karyotyping
Karyotyping of the iPS cells was performed as described in Campos et
al. (2009), followed byG-Banding.Metaphaseswere imaged using a Zeiss
Axioskop, 60×, and analysed using Ikaros software (Metasystems). At
least 30 metaphases were counted.
Embryoid body (EB) formation and directed differentiation
For EB formation, iPSC colonies were ﬁrst dissociated to single cells
usingAccutase® (Sigma-Aldrich), counted and cultured, hanging as sin-
gle drops of 2000 cells/20 μl on lids of Petri dishes in E8medium supple-
mented with 4 mg/ml polyvinyl alcohol.
For differentiation into germ layer precursors, small molecules were
used as described in Frank et al. (2012). Brieﬂy, for differentiation to
neuroectoderm, 5 days of treatment with FTDAmedium supplemented
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was applied. For mesodermal differentiation, treatment for 2 days with
10 ng/ml FGF2, 5 ng/ml Activin A, 10 ng/ml BMP4 (R&D), and 5 mM
CHIR99021 was carried out. Endodermal differentiation was induced
by treatment with 10 ng/ml FGF2, 100 ng/ml Activin A, 10 ng/ml
BMP4, and 5mMCHIR99021 for 1 day, and thenwith 100 ng/ml Activin
A for 3 days. Following this treatment, plated cells were immunostained
for germ layer-speciﬁc markers.
Immunocytochemistry
Expression of pluripotency and germ layer markers was veriﬁed
using immunocytochemical staining on cells plated on coverslips. Cells
were ﬁxed in 4% PFA (15 min, room temperature (RT)), permeabilized
(with the exception of surface markers) with 0.1 M Glycine and 0.25%
triton in PBS (10min, RT). This was followed by blocking in 30% normal
goat serum (1 h, RT) and incubation with primary (overnight, 4 °C) and
secondary (1 h, RT) antibodies (Table 1) in 2% BSA/PBS. Nuclei were
stained using 1 μg/ml DAPI. Cells were imaged using a Leica DMI6000 B.Acknowledgements
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